Correction: The Validation and Clinical Implementation of BRCAplus: A Comprehensive High-Risk Breast Cancer Diagnostic Assay
Main Author: | The Staff |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178226/?tool=EBI |
Similar Items
-
Correction: The Validation and Clinical Implementation of BRCAplus: A Comprehensive High-Risk Breast Cancer Diagnostic Assay.
Published: (2014-01-01) -
The validation and clinical implementation of BRCAplus: a comprehensive high-risk breast cancer diagnostic assay.
by: Hansook Kim Chong, et al.
Published: (2014-01-01) -
Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.
by: PLOS ONE Staff
Published: (2017-01-01) -
Correction: Multi-Centre Evaluation of the Determine HIV Combo Assay when Used for Point of Care Testing in a High Risk Clinic-Based Population
by: The Staff
Published: (2014-01-01) -
Development and validation of an immunohistochemistry assay to assess glucocorticoid receptor expression for clinical trials of mifepristone in breast cancer
by: Baker GM, et al.
Published: (2015-12-01)